IRTC
iRhythm Technologies Inc

1,555
Mkt Cap
$5.96B
Volume
501,784.00
52W High
$212.00
52W Low
$71.00
PE Ratio
-114.14
IRTC Fundamentals
Price
$181.10
Prev Close
$185.00
Open
$182.68
50D MA
$177.32
Beta
1.04
Avg. Volume
381,527.83
EPS (Annual)
-$3.63
P/B
48.88
Rev/Employee
$295,919.50
Loading...
Loading...
News
all
press releases
iRhythm Technologies (IRTC) Reports Q3 Loss, Beats Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of +83.33% and +4.97%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5d ago
News Placeholder
More News
News Placeholder
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders. If...
Business Wire·12d ago
News Placeholder
IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection
iRhythm's AMALFI trial shows its Zio monitoring service boosts AF detection and speeds diagnosis, strengthening its edge in cardiac care.
Zacks·2mo ago
News Placeholder
Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?
Tempus AI's soaring Q2 revenues, margin gains and near-EBITDA breakeven position it as a fast-rising force in precision medicine.
Zacks·3mo ago
News Placeholder
iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of +39.62% and +7.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Hims & Hers Health, Inc. (HIMS) Reports Next Week: Wall Street Expects Earnings Growth
Hims & Hers Health (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3mo ago
News Placeholder
Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know
iRhythm Technologies (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3mo ago
News Placeholder
Tempus AI Gains FDA Nod Amid Booming AI ECG Market Momentum
TEM secures FDA clearance for its AI-powered ECG tool targeting heart failure, as AI ECG adoption accelerates.
Zacks·3mo ago
News Placeholder
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?
TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.
Zacks·4mo ago
News Placeholder
Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?
Zacks·5mo ago

Latest IRTC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.